LGM
KRTX

Logos Global Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Logos Global Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-90,000
Closed -$28.5M – 77
2023
Q4 		$28.5M Sell
90,000
-25,000
-22% -$4.86M 2.66% 13
2023
Q3 		$19.4M Buy
115,000
+80,000
+229% +$15M 2.59% 14
2023
Q2 		$7.59M Sell
35,000
-65,000
-65% -$13.9M 1.03% 30
2023
Q1 		$18.2M Sell
100,000
-50,000
-33% -$9.56M 2.6% 14
2022
Q4 		$29.5M Hold
150,000
– – 3.45% 9
2022
Q3 		$33.7M Hold
150,000
– – 4.15% 9
2022
Q2 		$19M Sell
150,000
-190,000
-56% -$21.8M 3.48% 13
2022
Q1 		$43.1M Buy
340,000
+40,000
+13% +$4.5M 5.59% 7
2021
Q4 		$39.3M Sell
300,000
-160,000
-35% -$20.7M 4.05% 7
2021
Q3 		$56.3M Buy
460,000
+135,000
+42% +$15.6M 4.06% 6
2021
Q2 		$37M Buy
325,000
+125,000
+63% +$14.6M 3.11% 7
2021
Q1 		$24M Buy
200,000
+80,000
+67% +$9.06M 2.35% 11
2020
Q4 		$12.2M Buy
+120,000
New +$11.1M 1.05% 22
2020
Q2 		– Sell
-69,658
Closed -$5.01M – 67
2020
Q1 		$5.01M Buy
69,658
+30,011
+76% +$2.57M 1.91% 19
2019
Q4 		$2.99M Buy
+39,647
New +$1.74M 0.74% 30

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Logos Global Management's KRTX Position: Q1 2024 in Review

Logos Global Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 90,000 shares — an estimated $28.5M sold.

Logos Global Management first reported a position in KRTX in Q4 2019 and held it in 15 quarters. The position peaked at $56.3M in Q3 2021. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Logos Global Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Logos Global Management sold 90,000 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $28.5M.
  • Logos Global Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 15 quarters.
  • Logos Global Management's Karuna Therapeutics, Inc. Common Stock position peaked at $56.3M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Logos Global Management's 13F filing for Q1 2024, filed 15 May 2024.